ORKA stock

Oruka Therapeutics, Inc. (ORKA) stock news · $4.27B cap

Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.

This ORKA news page leads with what Oruka Therapeutics, Inc. filed — not a scraped headline mill.

No cached 8-K sentence for ORKA yet. We will not pad this page with generic market recap.

Latest reported ORKA revenue for 2023-12-31 was $0. Net income was -$5.3M. ORKA currently screens at market cap $4.27B.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the ORKA stock page; for the tape open the quote page.

ORKA stock news FAQ

What is ORKA's latest net income?

Latest cached Oruka Therapeutics, Inc. (ORKA) net income was -$5.3M. Statements: https://lician.com/financials/orka

What is ORKA's market cap?

Oruka Therapeutics, Inc. (ORKA) market cap is $4.27B on the latest cached fundamentals snapshot.

What kind of company is ORKA?

Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.

Where is ORKA stock news listed?

Cached stock news for Oruka Therapeutics, Inc. (ORKA) is listed at https://lician.com/news/orka. Filings: https://lician.com/sec/orka

Not investment advice.

Full ORKA analysis